 | • レポートコード：MRC2-11QY11296 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はセリアック病のグローバル市場について調査・分析したレポートです。種類別（膨満、下痢、食欲不振、その他）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別セリアック病の競争状況、市場シェア ・世界のセリアック病市場：種類別市場規模 2015年-2020年（膨満、下痢、食欲不振、その他） ・世界のセリアック病市場：種類別市場規模予測 2021年-2026年（膨満、下痢、食欲不振、その他） ・世界のセリアック病市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界のセリアック病市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米のセリアック病市場分析：米国、カナダ ・ヨーロッパのセリアック病市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのセリアック病市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のセリアック病市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのセリアック病市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Merck、Johnson & Johnson、BiolineRx、Pfizer、Innovate Biopharmaceuticals、ImmusanT、Novartis、Bristol-Myers Squibb、Immunomedics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Celiac Disease Market
The global Celiac Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Celiac Disease Scope and Market Size
Celiac Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Celiac Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Bristol-Myers Squibb
Immunomedics
Market segment by Type, the product can be split into
Distension
Diarrhea
Anorexia
Others
Market segment by Application, split into
Hospital
Clinic
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Celiac Disease Revenue
1.4 Market by Type
1.4.1 Global Celiac Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Distension
1.4.3 Diarrhea
1.4.4 Anorexia
1.4.5 Others
1.5 Market by Application
1.5.1 Global Celiac Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Celiac Disease Market Perspective (2015-2026)
2.2 Global Celiac Disease Growth Trends by Regions
2.2.1 Celiac Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Celiac Disease Historic Market Share by Regions (2015-2020)
2.2.3 Celiac Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Celiac Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Celiac Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Celiac Disease Players by Market Size
3.1.1 Global Top Celiac Disease Players by Revenue (2015-2020)
3.1.2 Global Celiac Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Celiac Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Celiac Disease Market Concentration Ratio
3.2.1 Global Celiac Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Celiac Disease Revenue in 2019
3.3 Celiac Disease Key Players Head office and Area Served
3.4 Key Players Celiac Disease Product Solution and Service
3.5 Date of Enter into Celiac Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Celiac Disease Historic Market Size by Type (2015-2020)
4.2 Global Celiac Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Celiac Disease Market Size by Application (2015-2020)
5.2 Global Celiac Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Celiac Disease Market Size (2015-2020)
6.2 Celiac Disease Key Players in North America (2019-2020)
6.3 North America Celiac Disease Market Size by Type (2015-2020)
6.4 North America Celiac Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Celiac Disease Market Size (2015-2020)
7.2 Celiac Disease Key Players in Europe (2019-2020)
7.3 Europe Celiac Disease Market Size by Type (2015-2020)
7.4 Europe Celiac Disease Market Size by Application (2015-2020)
8 China
8.1 China Celiac Disease Market Size (2015-2020)
8.2 Celiac Disease Key Players in China (2019-2020)
8.3 China Celiac Disease Market Size by Type (2015-2020)
8.4 China Celiac Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Celiac Disease Market Size (2015-2020)
9.2 Celiac Disease Key Players in Japan (2019-2020)
9.3 Japan Celiac Disease Market Size by Type (2015-2020)
9.4 Japan Celiac Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Celiac Disease Market Size (2015-2020)
10.2 Celiac Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Celiac Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Celiac Disease Market Size by Application (2015-2020)
11 India
11.1 India Celiac Disease Market Size (2015-2020)
11.2 Celiac Disease Key Players in India (2019-2020)
11.3 India Celiac Disease Market Size by Type (2015-2020)
11.4 India Celiac Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Celiac Disease Market Size (2015-2020)
12.2 Celiac Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Celiac Disease Market Size by Type (2015-2020)
12.4 Central & South America Celiac Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Celiac Disease Introduction
13.1.4 Roche Revenue in Celiac Disease Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Celiac Disease Introduction
13.2.4 Merck Revenue in Celiac Disease Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Celiac Disease Introduction
13.3.4 Johnson & Johnson Revenue in Celiac Disease Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 BiolineRx
13.4.1 BiolineRx Company Details
13.4.2 BiolineRx Business Overview
13.4.3 BiolineRx Celiac Disease Introduction
13.4.4 BiolineRx Revenue in Celiac Disease Business (2015-2020)
13.4.5 BiolineRx Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Celiac Disease Introduction
13.5.4 Pfizer Revenue in Celiac Disease Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Innovate Biopharmaceuticals
13.6.1 Innovate Biopharmaceuticals Company Details
13.6.2 Innovate Biopharmaceuticals Business Overview
13.6.3 Innovate Biopharmaceuticals Celiac Disease Introduction
13.6.4 Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2015-2020)
13.6.5 Innovate Biopharmaceuticals Recent Development
13.7 ImmusanT
13.7.1 ImmusanT Company Details
13.7.2 ImmusanT Business Overview
13.7.3 ImmusanT Celiac Disease Introduction
13.7.4 ImmusanT Revenue in Celiac Disease Business (2015-2020)
13.7.5 ImmusanT Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Celiac Disease Introduction
13.8.4 Novartis Revenue in Celiac Disease Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Bristol-Myers Squibb
13.9.1 Bristol-Myers Squibb Company Details
13.9.2 Bristol-Myers Squibb Business Overview
13.9.3 Bristol-Myers Squibb Celiac Disease Introduction
13.9.4 Bristol-Myers Squibb Revenue in Celiac Disease Business (2015-2020)
13.9.5 Bristol-Myers Squibb Recent Development
13.10 Immunomedics
13.10.1 Immunomedics Company Details
13.10.2 Immunomedics Business Overview
13.10.3 Immunomedics Celiac Disease Introduction
13.10.4 Immunomedics Revenue in Celiac Disease Business (2015-2020)
13.10.5 Immunomedics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Celiac Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Celiac Disease Revenue
Table 3. Ranking of Global Top Celiac Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Celiac Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Distension
Table 6. Key Players of Diarrhea
Table 7. Key Players of Anorexia
Table 8. Key Players of Others
Table 9. Global Celiac Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Celiac Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Celiac Disease Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Celiac Disease Market Share by Regions (2015-2020)
Table 13. Global Celiac Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Celiac Disease Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Celiac Disease Market Growth Strategy
Table 19. Main Points Interviewed from Key Celiac Disease Players
Table 20. Global Celiac Disease Revenue by Players (2015-2020) (Million US$)
Table 21. Global Celiac Disease Market Share by Players (2015-2020)
Table 22. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celiac Disease as of 2019)
Table 23. Global Celiac Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Celiac Disease Product Solution and Service
Table 26. Date of Enter into Celiac Disease Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Celiac Disease Market Size by Type (2015-2020) (Million US$)
Table 29. Global Celiac Disease Market Size Share by Type (2015-2020)
Table 30. Global Celiac Disease Revenue Market Share by Type (2021-2026)
Table 31. Global Celiac Disease Market Size Share by Application (2015-2020)
Table 32. Global Celiac Disease Market Size by Application (2015-2020) (Million US$)
Table 33. Global Celiac Disease Market Size Share by Application (2021-2026)
Table 34. North America Key Players Celiac Disease Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Celiac Disease Market Share (2019-2020)
Table 36. North America Celiac Disease Market Size by Type (2015-2020) (Million US$)
Table 37. North America Celiac Disease Market Share by Type (2015-2020)
Table 38. North America Celiac Disease Market Size by Application (2015-2020) (Million US$)
Table 39. North America Celiac Disease Market Share by Application (2015-2020)
Table 40. Europe Key Players Celiac Disease Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Celiac Disease Market Share (2019-2020)
Table 42. Europe Celiac Disease Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Celiac Disease Market Share by Type (2015-2020)
Table 44. Europe Celiac Disease Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Celiac Disease Market Share by Application (2015-2020)
Table 46. China Key Players Celiac Disease Revenue (2019-2020) (Million US$)
Table 47. China Key Players Celiac Disease Market Share (2019-2020)
Table 48. China Celiac Disease Market Size by Type (2015-2020) (Million US$)
Table 49. China Celiac Disease Market Share by Type (2015-2020)
Table 50. China Celiac Disease Market Size by Application (2015-2020) (Million US$)
Table 51. China Celiac Disease Market Share by Application (2015-2020)
Table 52. Japan Key Players Celiac Disease Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Celiac Disease Market Share (2019-2020)
Table 54. Japan Celiac Disease Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Celiac Disease Market Share by Type (2015-2020)
Table 56. Japan Celiac Disease Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Celiac Disease Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Celiac Disease Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Celiac Disease Market Share (2019-2020)
Table 60. Southeast Asia Celiac Disease Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Celiac Disease Market Share by Type (2015-2020)
Table 62. Southeast Asia Celiac Disease Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Celiac Disease Market Share by Application (2015-2020)
Table 64. India Key Players Celiac Disease Revenue (2019-2020) (Million US$)
Table 65. India Key Players Celiac Disease Market Share (2019-2020)
Table 66. India Celiac Disease Market Size by Type (2015-2020) (Million US$)
Table 67. India Celiac Disease Market Share by Type (2015-2020)
Table 68. India Celiac Disease Market Size by Application (2015-2020) (Million US$)
Table 69. India Celiac Disease Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Celiac Disease Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Celiac Disease Market Share (2019-2020)
Table 72. Central & South America Celiac Disease Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Celiac Disease Market Share by Type (2015-2020)
Table 74. Central & South America Celiac Disease Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Celiac Disease Market Share by Application (2015-2020)
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Product
Table 79. Roche Revenue in Celiac Disease Business (2015-2020) (Million US$)
Table 80. Roche Recent Development
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Product
Table 84. Merck Revenue in Celiac Disease Business (2015-2020) (Million US$)
Table 85. Merck Recent Development
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Product
Table 89. Johnson & Johnson Revenue in Celiac Disease Business (2015-2020) (Million US$)
Table 90. Johnson & Johnson Recent Development
Table 91. BiolineRx Company Details
Table 92. BiolineRx Business Overview
Table 93. BiolineRx Product
Table 94. BiolineRx Revenue in Celiac Disease Business (2015-2020) (Million US$)
Table 95. BiolineRx Recent Development
Table 96. Pfizer Company Details
Table 97. Pfizer Business Overview
Table 98. Pfizer Product
Table 99. Pfizer Revenue in Celiac Disease Business (2015-2020) (Million US$)
Table 100. Pfizer Recent Development
Table 101. Innovate Biopharmaceuticals Company Details
Table 102. Innovate Biopharmaceuticals Business Overview
Table 103. Innovate Biopharmaceuticals Product
Table 104. Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2015-2020) (Million US$)
Table 105. Innovate Biopharmaceuticals Recent Development
Table 106. ImmusanT Company Details
Table 107. ImmusanT Business Overview
Table 108. ImmusanT Product
Table 109. ImmusanT Revenue in Celiac Disease Business (2015-2020) (Million US$)
Table 110. ImmusanT Recent Development
Table 111. Novartis Business Overview
Table 112. Novartis Product
Table 113. Novartis Company Details
Table 114. Novartis Revenue in Celiac Disease Business (2015-2020) (Million US$)
Table 115. Novartis Recent Development
Table 116. Bristol-Myers Squibb Company Details
Table 117. Bristol-Myers Squibb Business Overview
Table 118. Bristol-Myers Squibb Product
Table 119. Bristol-Myers Squibb Revenue in Celiac Disease Business (2015-2020) (Million US$)
Table 120. Bristol-Myers Squibb Recent Development
Table 121. Immunomedics Company Details
Table 122. Immunomedics Business Overview
Table 123. Immunomedics Product
Table 124. Immunomedics Revenue in Celiac Disease Business (2015-2020) (Million US$)
Table 125. Immunomedics Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Celiac Disease Market Share by Type: 2020 VS 2026
Figure 2. Distension Features
Figure 3. Diarrhea Features
Figure 4. Anorexia Features
Figure 5. Others Features
Figure 6. Global Celiac Disease Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Celiac Disease Report Years Considered
Figure 10. Global Celiac Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Celiac Disease Market Share by Regions: 2020 VS 2026
Figure 12. Global Celiac Disease Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Celiac Disease Market Share by Players in 2019
Figure 15. Global Top Celiac Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celiac Disease as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Celiac Disease Revenue in 2019
Figure 17. North America Celiac Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Celiac Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Celiac Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Celiac Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Celiac Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Celiac Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Celiac Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
セリアック病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Celiac Disease Drug Market The global Celiac Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Celiac Disease Drug Scope and Market Size Celiac Disease Drug market is seg…- セリアック治療薬の世界市場（～2026年） Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine…
- 院内感染症検査の世界市場（～2026年） Hosptial infection is categorized based on infection types into the following segments: blood stream infection (BSI) testing, urinary tract infection (UTI) testing, methicilin-resistant staphylococcus aureus (MRSA) testing, pneumonia testing, surgical site infection (SSI) testing & others infections…
- 非アルコール性脂肪肝疾患治療薬の世界市場（～2026年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …
- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…